about
Prognostic impact of moderate or severe mitral regurgitation (MR) irrespective of concomitant comorbidities: a retrospective matched cohort study.Randomized Comparison of High-Sensitivity Troponin Reporting in Undifferentiated Chest Pain Assessment.A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: Design of the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T (RAPID-TnT) study.Rational clinical evaluation of suspected acute coronary syndromes: The value of more information.The predictive value of high sensitivity-troponin velocity within the first 6h of presentation for cardiac outcomes regardless of acute coronary syndrome diagnosis.High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causality.Variation in coronary angiography rates in Australia: correlations with socio-demographic, health service and disease burden indices.International Mobile-Health Intervention on Physical Activity, Sitting, and Weight: The Stepathlon Cardiovascular Health Study.Screening for important unwarranted variation in clinical practice: a triple-test of processes of care, costs and patient outcomes.Variation in Clinical Practice: A Priority Setting Approach to the Staged Funding of Quality Improvement.Condition-specific Streaming versus an Acuity-based Model of Cardiovascular Care: A Historically-controlled Quality Improvement Study Evaluating the Association with Early Clinical Events.An examination of clinical intuition in risk assessment among acute coronary syndromes patients: observations from a prospective multi-center international observational registry.Has invasive management for acute coronary syndromes become more 'risk-appropriate': pooled results of five Australian registries.Cost effectiveness of high-sensitivity troponin compared to conventional troponin among patients presenting with undifferentiated chest pain: A trial based analysis.Invasive management of acute coronary syndrome: Interaction with competing risksImpact of patient's health-related quality of life on physicians' therapy and perceived benefit in acute coronary syndromes: protocol for a systemic review of quantitative and qualitative studiesThe appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial designPatterns of inflammatory activation associated with precipitants of acute coronary syndromes: a case-crossover studyPerceived risk of ischemic and bleeding events in acute coronary syndromesEffect of Balloon Aortic Valvuloplasty on Mortality in Patients With Severe Aortic Stenosis Prior to Conservative Treatment and Surgical or Transcatheter Aortic Valve ReplacementThe Impact of Cardiac Rehabilitation and Secondary Prevention Programs on 12-Month Clinical Outcomes: A Linked Data AnalysisMultidisciplinary transcatheter aortic valve replacement heart team programme improves mortality in aortic stenosisA Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT)
P50
Q33996485-576B2609-6A47-4352-B582-0CAF99AB9EE3Q38389050-F1231A6C-FD3D-455C-BA67-285C43B07AF6Q38651204-CF366883-19DD-4EB1-99B7-A49D658E986FQ38749095-9AD2E107-CB28-4354-BEBE-DC3F14A1C4A1Q38933257-A3352F8C-3D5E-408F-B396-4C5697D69BF1Q39076586-875408E9-A50E-430B-869F-E6916DD31C28Q39552645-1C5C673F-91CF-4A9B-B093-82BBD1CEFC14Q39859308-85BF4859-BD6D-45E3-BA12-71B7EF76513EQ39954430-F18B7844-399F-476F-B6D4-B2073F217918Q41337434-A72B66C7-B509-4FEA-A1FD-FF6DEE4F3D0CQ41565580-2611D7B7-C41F-4A1C-80C3-E8CFDF4A3DD1Q43754474-B3A716AC-3493-47C7-AF64-F9D66DA1B7D2Q47960498-450796ED-4F76-435D-A916-82A1BD8106B1Q53117742-6B26F37E-1F13-4E79-A343-055D3AC4CEABQ57463927-E11D2B74-CFE5-44C6-BDBD-28E60D217F5EQ64093972-1A038887-22AA-4DB3-8226-220ACE77538DQ64120256-DCADA280-4AE9-465B-A6F9-78C2EA55BF3EQ84869953-552CD437-7FA2-4EEA-8BCF-E080C7E00044Q86736496-6CEEFAC7-C748-4622-AED1-577ADD8C0296Q91720253-04748D5F-A852-4D3B-A8C1-DE7532EFE77BQ91896503-DFCE42ED-B21C-45BB-926C-B4D42AAD88EAQ92627943-10DA1D0B-AE1B-483D-821A-DCBB25A5B08BQ93070160-F0B61D75-90D0-4332-9408-5F04101AD1A0
P50
description
investigador
@es
researcher
@en
name
M Horsfall
@en
type
label
M Horsfall
@en
prefLabel
M Horsfall
@en
P31
P496
0000-0002-5755-4018